Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate-specific antigen levels

Urology

Volumn 47, Issue 3, 1996, Pages 347-352

  Roehrborn, Claus G ^a   Pickens, G John ^b   Sanders, Jeffrey S ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ANTIGEN DETECTION; ARTICLE; DATA ANALYSIS; DATA BASE; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; TISSUE SECTION; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0029961163     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80451-8     Document Type: Article

References (12)

1. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, and Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161, 1991.
2. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, and Emond J: Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 147: 846-852, 1992.
3. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, and Lange PH: Screening for prostatic carcinoma with prostate-specific antigen. J Urol 147: 841-845, 1992.
4. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol 151: 1283-1290, 1994.
5. Coplen DE, Andriole GL, Yuan JJ, and Catalona WJ: The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia. J Urol 146: 75-77, 1991.
6. Hodge KK, McNeal JE, Terris MK, and Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142: 71-74, 1989.
7. Thompson IM, Rounder JB, Teague JL, Peek M, and Spence CR: Impact of routine screening for adenocarcinoma of the prostate on stage distribution. J Urol 137: 424-426, 1987.
8. Chodak GW, Keller P, and Schoenberg HW: Assessment of screening for prostate cancer using the digital rectal examination. J Urol 141: 1136-1138, 1989.
9. Boring CC, Squires TS, and Tong T: Cancer statistics, 1993. CA Cancer J Clin 43: 7-26, 1993.
10. Catalona WJ, Smith DS, Ratliff TL, and Basler JW: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948-954, 1993.
11. Vallancien G, Prapotnich D, Veillon B, Brisset JM, and Andre-Bougaran J: Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146: 1308-1312, 1991.
12. Keetch DW, Catalona WJ, and Smith DS: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151: 1571-1574, 1994.